報價延遲最少15分鐘:2026/04/03 15:58 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
108.49 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
2.52/3.17
|
|
企業價值
2.66B
|
| 資產負債 |
|
每股賬面淨值
17.28
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
249.60M
|
|
每股收益
8.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded productsused in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas. |
